Browsing by Author "Charalambous, E."
Now showing items 1-6 of 6
-
Article
Amelioration of crushed brick - lime composites using nano-additives
Theodoridou, Magdalini; Charalambous, E.; Maravelaki-Kalaitzaki, P.; Ioannou, Ioannis (2016)Crushed brick is widely known as a pozzolanic additive for composite building materials. However, crushed brick - lime composites usually show high porosity, low compressive strength and slow reaction kinetics. In this ...
-
Article
Amelioration of crushed brick - lime composites using nano-additives
Theodoridou, Magdalini; Charalambous, E.; Maravelaki-Kalaitzaki, P.; Ioannou, Ioannis (2016)Crushed brick is widely known as a pozzolanic additive for composite building materials. However, crushed brick - lime composites usually show high porosity, low compressive strength and slow reaction kinetics. In this ...
-
Article
An experimental design for the classification of archaeological ceramic data from Cyprus, and the tracing of inter-class relationships
Charalambous, E.; Dikomitou-Eliadou, M.; Milis, G. M.; Mitsis, Georgios D.; Eliades, D. G. (2016)
-
Article
Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group
Pentheroudakis, George; Kotteas, E. A.; Kotoula, V.; Papadopoulou, K.; Charalambous, E.; Cervantes, A.; Ciuleanu, T.; Fountzilas, George; Pavlidis, Nicholas (2014)Cancer of unknown primary origin (CUP) had a poor prognosis, determined by clinico-histological characteristics, partly due to the lack of insights on its biology. We screened tumour DNA from 87 patients with CUP for CTNNB1 ...
-
Article
Promoting quality and equity in socially disadvantaged schools: A group- randomisation study
Charalambous, E.; Kyriakides, Leonidas; Creemers, Bert P. M. (2015)This study investigates the impact of the Dynamic Approach to School Improvement (DASI) on promoting quality and equity. Forty primary schools in socially disadvantaged areas were randomly split into two groups. The control ...
-
Article
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic Cooperative Oncology Group (HeCOG)
Pentheroudakis, George; Kotoula, V.; Fountzilas, E.; Kouvatseas, G.; Basdanis, G.; Xanthakis, I.; Makatsoris, T.; Charalambous, E.; Papamichael, D.; Samantas, E.; Papakostas, P.; Bafaloukos, Dimitrios; Razi, E. D.; Christodoulou, C.; Varthalitis, I.; Pavlidis, Nicholas; Fountzilas, George (2014)Background: Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor ...